Atlas Trials

Liver Fibrosis Due to NASH

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Liver Fibrosis Due to NASH

RecordFirmDate
Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population. (NCT06797596)Fibronostics USA, Inc2025-05-01
Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) (NCT01672866)Gilead Sciences2012-12-05
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH (NCT01672879)Gilead Sciences2012-10-29

Track Liver Fibrosis Due to NASH automatically

Every clearance here is in the API, with alerts when new ones post.